FDA Inspection 1133939 — Antoinette Pragalos MD
The FDA completed an inspection of Antoinette Pragalos MD on December 2, 2020 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 2, 2020
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Cincinnati, OH (United States)
Additional Details
Clinical Investigator (CI)